Patterns of Initial and Intracranial Failure in Metastatic EGFR-mutant Non-Small Cell Lung Cancer Treated with Erlotinib

OBJECTIVES: Patients with metastatic EGFR-mutant (mEGFRmt) NSCLC have favorable survival when treated with erlotinib. We hypothesized that treatment failure in most patients is limited to initial sites of disease, in which case incorporating local therapy such as radiation might further delay progre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer
Main Authors: Patel, Suchit H., Rimner, Andreas, Foster, Amanda, Zhang, Zhigang, Woo, Kaitlin M., Yu, Helena A., Riely, Gregory J., Wu, Abraham J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477661/
https://ncbi.nlm.nih.gov/pubmed/28625621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2017.03.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados